Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Tanaka

Showing results (251-260 of 349) with videos related to

Pageof 35
Sort By:
Scientific Reports|September 28, 2016
Helium and methane sources and fluxes of shallow submarine hydrothermal plumes near the Tokara Islands, Southern JapanHsin-Yi Wen, Yuji Sano, Naoto Takahata, et al.
Translational Lung Cancer Research|December 15, 2022
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancerRitsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2021
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trialKentaro Tanaka, Hajime Asahina, Junji Kishimoto, et al.
International Journal of Cancer|May 2, 2020
Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapyShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.
Journal of Cancer Research and Clinical Oncology|February 7, 2020
Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitorsKazuki Takada, Yasuto Yoneshima, Kentaro Tanaka, et al.
Heart and Vessels|July 9, 2023
The estimation of coronary artery calcium thickness by computed tomography angiography based on optical coherence tomography measurementsMasaaki Okutsu, Satoru Mitomo, Hirokazu Onishi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 12, 2022
AVP-eGFP was significantly upregulated by hypovolemia in the parvocellular division of the paraventricular nucleus in the transgenic ratsKenya Sanada, Hiromichi Ueno, Tetsu Miyamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|October 23, 2019
Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti-PD-1 therapyYuki Ikematsu, Kentaro Tanaka, Toyoshi Yanagihara, et al.
Diagnostics (Basel, Switzerland)|November 18, 2020
Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription FactorsYounosuke Sato, Isamu Okamoto, Hiroki Kameyama, et al.
Clinical Lung Cancer|July 3, 2020
Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non-small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834)Satoru Miura, Takeharu Yamanaka, Terufumi Kato, et al.
Pageof 35

Showing results (251-260 of 349) with videos related to

Sort By:
Pageof 35
Scientific Reports|September 28, 2016
Helium and methane sources and fluxes of shallow submarine hydrothermal plumes near the Tokara Islands, Southern JapanHsin-Yi Wen, Yuji Sano, Naoto Takahata, et al.
Translational Lung Cancer Research|December 15, 2022
Association of thyroid transcription factor-1 (TTF-1) expression with efficacy of PD-1/PD-L1 inhibitors plus pemetrexed and platinum chemotherapy in advanced non-squamous non-small cell lung cancerRitsu Ibusuki, Yasuto Yoneshima, Mikiko Hashisako, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2021
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trialKentaro Tanaka, Hajime Asahina, Junji Kishimoto, et al.
International Journal of Cancer|May 2, 2020
Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapyShinkichi Takamori, Kazuki Takada, Mototsugu Shimokawa, et al.
Journal of Cancer Research and Clinical Oncology|February 7, 2020
Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitorsKazuki Takada, Yasuto Yoneshima, Kentaro Tanaka, et al.
Heart and Vessels|July 9, 2023
The estimation of coronary artery calcium thickness by computed tomography angiography based on optical coherence tomography measurementsMasaaki Okutsu, Satoru Mitomo, Hirokazu Onishi, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 12, 2022
AVP-eGFP was significantly upregulated by hypovolemia in the parvocellular division of the paraventricular nucleus in the transgenic ratsKenya Sanada, Hiromichi Ueno, Tetsu Miyamoto, et al.
Lung Cancer (Amsterdam, Netherlands)|October 23, 2019
Immune checkpoint protein and cytokine expression by T lymphocytes in pleural effusion of cancer patients receiving anti-PD-1 therapyYuki Ikematsu, Kentaro Tanaka, Toyoshi Yanagihara, et al.
Diagnostics (Basel, Switzerland)|November 18, 2020
Integrated Immunohistochemical Study on Small-Cell Carcinoma of the Lung Focusing on Transcription and Co-Transcription FactorsYounosuke Sato, Isamu Okamoto, Hiroki Kameyama, et al.
Clinical Lung Cancer|July 3, 2020
Treatment Rationale and Design of a Phase III Study of Afatinib or Chemotherapy in Patients with Non-small-cell Lung Cancer Harboring Sensitizing Uncommon Epidermal Growth Factor Receptor Mutations (ACHILLES/TORG1834)Satoru Miura, Takeharu Yamanaka, Terufumi Kato, et al.
Pageof 35